Safety Study of Nebivolol for COPD Patients

• Status: Withdrawn
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Chicago
• Collaborator: Forest Laboratories
• Treatments: Nebivolol

Criteria

Inclusion Criteria:

• Clinical diagnosis of high blood pressure and chronic obstructive pulmonary disease (COPD)

Exclusion Criteria:

• Asthma; Heart failur;

• End stage kidney disease;

• acute myocardial infarction,unstable angina, stroke or TIA within the past year;

• Females who are pregnant, lactating or women of childbearing potential who are not using approved method of contraception.